Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...
Recent research indicates that colon cancer patients with circulating tumor DNA post-surgery may improve their survival likelihood with daily celecoxib use. Celecoxib, a COX-2 inhibitor, significantly ...